Oral Biology, Universidade do Sagrado Coração (USC), São Paulo, Brazil.
Endocrinology, Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil.
Lasers Med Sci. 2019 Aug;34(6):1081-1088. doi: 10.1007/s10103-019-02810-8. Epub 2019 Jun 1.
This study aimed to evaluate, through histomorphometric analysis, the bone repair process in the tibia of rats treated with zoledronic acid and submitted to 808-nm low-level laser therapy (LLLT) by using arsenide aluminum gallium laser. For this purpose, 20 rats were used and distributed according to treatment: group 1-saline administration; group 2-treated with LLLT; group 3-treated with zoledronic acid; and group 4-treated with zoledronic acid and LLLT. The zoledronic acid was administered at a dose of 0.035 mg/kg every 2 weeks for 8 weeks. Subsequently, bone defects of 2 mm were prepared in the tibias of all groups. The bone defects in groups 2 and 4 were irradiated with LLLT in the immediate post-operative period. After 14 and 28 days of application, the animals were submitted and euthanized for histomorphometric analysis. The results were submitted to statistical analysis (α = 5%), and the intragroup comparison was performed using the t test. On the other hand, for intergroup comparison, the ANOVA test was performed, and to the groups presenting statistically significant difference, the Student-Newman-Keuls test was used. In intergroup comparison, group 1 (mean ± SD= 45.2 ± 18.56%) showed a lower bone formation compared with groups 2 (64.13 ± 3.51%) (p = 0.358) and 4 (15.2 ± 78.22%) (p = 0.049), at the 14-day period. Group 3 (20.99 ± 7.42%) also presented a lower amount of neoformed bone tissue, with statistically significant difference when compared with groups 1 (p = 0.002), 2, and 4 (p ≤ 0,001). After 28 days, group 1 presented a lower amount of neoformed bone tissue compared with the other groups, with p = 0.020. Thus, it was concluded that LLLT associated with zoledronic acid is effective for stimulating bone formation in surgically created defects in rats, at the periods studied.
本研究旨在通过组织形态计量分析评估,在接受唑来膦酸治疗并接受砷化铝镓激光 808nm 低水平激光治疗(LLLT)的大鼠的胫骨中,骨修复过程。为此,使用了 20 只大鼠,并根据治疗方法进行了分组:第 1 组-生理盐水给药;第 2 组-接受 LLLT 治疗;第 3 组-接受唑来膦酸治疗;第 4 组-接受唑来膦酸和 LLLT 治疗。唑来膦酸每 2 周以 0.035mg/kg 的剂量给药,共 8 周。随后,在所有组的胫骨中制备 2mm 的骨缺损。在术后即刻,第 2 组和第 4 组的骨缺损用 LLLT 照射。在应用 14 和 28 天后,对动物进行处死并进行组织形态计量学分析。结果进行了统计学分析(α=5%),并通过 t 检验进行了组内比较。另一方面,对于组间比较,进行了方差分析,对于具有统计学显著差异的组,使用学生-纽曼-凯尔斯检验。在组间比较中,第 1 组(均值±SD=45.2±18.56%)在第 14 天与第 2 组(64.13±3.51%)(p=0.358)和第 4 组(15.2±78.22%)(p=0.049)相比,骨形成较少。第 3 组(20.99±7.42%)的新生骨组织量也较少,与第 1 组(p=0.002)、第 2 组和第 4 组(p≤0.001)相比具有统计学显著差异。在第 28 天,第 1 组与其他组相比,新生骨组织量较少,p=0.020。因此,结论是,在研究期间,LLLT 联合唑来膦酸可有效刺激大鼠手术造成的骨缺损中的骨形成。